Hopp til innhold


CeFH biostatistical meeting: Structured penalized regression for drug sensitivity prediction

Presentation by Manuela Zucknick, University of Oslo

Presentation by Manuela Zucknick, University of Oslo

29. Sep | 2020

Microsoft Teams
Speaker: Maneula Zucknick

Please contact us if you want to participate in the meeting.

Manuela Zucknick is Associate Professor at the Department of Biostatistics, University of Oslo. Her research is focussed on methods for statistical analysis of high dimensional data such as penalized regression and Bayesian methods.


Large-scale in vitro drug sensitivity screens are an important tool in personalized oncology to predict the effectiveness of potential cancer drugs. The prediction of the sensitivity of cancer cell lines to a panel of drugs is a multivariate regression problem with high-dimensional heterogeneous multi-omics data as input data and with potentially strong correlations between the outcome variables which represent the sensitivity to the different drugs. We propose a joint penalized regression approach with structured penalty terms which allow us to utilize the correlation structure between drugs with group-lasso-type penalties and at the same time address the heterogeneity between omics data sources by introducing data-source-specific penalty factors to penalize different data sources differently. By combining integrative penalty factors (IPF) with tree-guided group lasso, we create the IPF-tree-lasso method. We present a unified framework to transform more general IPF-type methods to the original penalized method. Because the structured penalty terms have multiple parameters, we demonstrate how the interval-search Efficient Parameter Selection via Global Optimization (EPSGO) algorithm can be used to optimize multiple penalty parameters efficiently. Simulation studies show that IPF-tree-lasso can improve the prediction performance compared to other lasso-type methods, in particular for heterogenous data sources. Finally, we employ the new methods to analyse data from the Genomics of Drug Sensitivity in Cancer project.


The Centre for Fertility and Health is a Centre of Excellence (SFF) at the Norwegian Institute of Public Health.